|

Low-dose aspirin Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Baby Aspirin

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

  • Weill Medical College of Cornell University1
  • University Hospital, Brest1
  • Mayo Clinic1

Indications

  • Cancer2
  • Chronic Coronary Disease1
  • High-risk Patients1
  • JAK2 V617F1
  • Prefibrotic/Early Primary Myelofibrosis1

Other1 trial

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
Phase 3

Scottsdale, Arizona1 trial

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Mayo Clinic in Arizona

Phase 2

Englewood, New Jersey1 trial

One-Month DAPT in CABG Patients

Englewood Hospital

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.